Aptus Capital Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $98k 1.0k 95.03
2024-06-30 $94k 1.0k 91.48
2024-03-31 $94k 1.0k 90.70

More positions owned by Aptus Capital Advisors

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Broadcom (AVGO)
Apple (AAPL)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Etf Ser Solutions Aptus Enhanced (JUCY)
Ishares Tr Core Msci Intl (IDEV)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Etf Ser Solutions Aptus Large Cap (DUBS)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Etf Ser Solutions Aptus Drawdown (ADME)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Aptus Capital Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Mirae Asset Global Investments
Thrivent Financial for Lutherans
Miller Investment Management
Northwestern Mutual Wealth Management Company
Prime Capital Investment Advisors
Bank of America Corporation
Financial Partners Group
LPL Financial
Mivtachim The Workers Social Insurance Fund
Phoenix Holdings
Morgan Stanley
J.Safra Asset Management

View all funds holding Vaneck Vectors Pharmaceutical etf